Riskpilot← Back to searchSign inGet full accessLeckström Medical AB
ABActiveOrg 5591689566Eklundsgatan 4General medical practice activities · NACE 8621Est. 20181-4 employees
Revenue 2024
SEK 285K
-71% vs 2023
EBITDA margin
3.4%
-98% vs 2023
Equity ratio
87.5%
Financial strength
Net profit 2024
SEK 51K
-90% vs 2023
| Revenue | SEK 285K | -71% |
| EBITDA | SEK 10K | -98% |
| Net profit | SEK 51K | -90% |
| Total assets | SEK 1,3M | -28% |
| Equity | SEK 1,1M | -12% |
| Employees | — | — |
Legal name
Leckström Medical AB
Org number
5591689566
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 augusti 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkartjänster, konsultationer och utbildning inom hälso- och sjukvård, förvaltning av värdepapper, fast och lös egendom jämte därmed förenlig verksamhet.
Address
Eklundsgatan 4
Email
leckstroem@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 512 | 1 022 | 953 | 990 | 285 |
| Staff expenses | — | — | −120 | −115 | −101 |
| EBITDA | 484 | 718 | 624 | 627 | 10 |
| Depreciation & amort. | −0 | −0 | — | — | −36 |
| EBIT | 484 | 718 | 624 | 627 | −27 |
| Net financials | — | — | −1 | 0 | 0 |
| Profit before tax | 363 | 718 | 623 | 627 | 78 |
| Tax | −78 | −140 | −129 | −130 | −27 |
| Net profit | 285 | 578 | 494 | 497 | 51 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 885 | 1 323 | 1 579 | 1 817 | 1 302 |
| Equity | 480 | 704 | 991 | 1 293 | 1 139 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 149 | 364 | 333 | 269 | 11 |
| Total debt | 149 | 364 | 333 | 269 | 11 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
87.5%
This company
38.2%
Market median
+129% vs market
20202024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20202024
Net profit margin
17.9%
This company
8.1%
Market median
+121% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Leckström Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joakim Carl Oskar Leckström | Deputy Board Member | 0 companies |
| Lucy Jane Parkinson | Deputy Board Member | 0 companies |
| Daniel Carl Tobias Leckström | Board of Directors | 0 companies |